Nerve growth factor (NGF), one of the most significant neurotrophic factors that vitally contributes to neuronal growth, survival, differentiation, and function maintenance, was once considered as an ideal therapeutic agent for the treatment of neurodegenerative diseases, such as Alzheimer’s disease (AD) [1]. Here, NGF is linked to early-onset autosomal dominant Alzheimer disease.